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and child can be averted (e. g. by means of medication, sur-
geries on the foetus in the mother’s womb and immediate 
post-natal therapy). However, there are no causal therapies 
for many of the disabilities that are focused on in prenatal 
diagnosis (such as trisomies 13, 18 and 21; see Fig. 1). If such 
a disability is discovered prenatally, the expectant parents are 
often confronted with the question of whether to continue or 
terminate the pregnancy. In Germany, an abortion is possible 
during the entire pregnancy if there is a so-called medical in-
dication. To do this, a doctor must attest the pregnant woman 
that abortion is the only way not to endanger her physical or 
mental health.
There are no uniformly collected national data with regard to 
the use and consequences of prenatal diagnostics. In various 
studies, it is unanimously pointed out that for most congeni-
tal disabilities, the abortion rate following a prenatal diagno-
sis is higher than 50 % (and higher than 85 % for trisomies 13, 
18 and 21). The novel NIPTs allow a medically largely risk-
free, very early prognosis regarding the presence of a foetal 
disability. Critics fear that, thus, the selection of unborn chil-
dren with disabilities will continue to expand.
Non-invasive prenatal tests
A comparatively new prenatal diagnostic procedure in the 
field of non-invasive procedures aims at the examination 
of cell-free »foetal« (actually placental) DNA from the 
mother’s blood. In these procedures – which are optional-
ly referred to as non-invasive prenatal tests, non-invasive 
prenatal diagnostics, cell-free DNA tests or simply blood 
tests  – taking a simple blood sample from the pregnant 
woman is the basis for making statements about the prob-
ability of genetically induced variations of the foetus. The 
Summary
 › In Germany, prenatal diagnostic procedures have been 
part of medical pregnancy care for 40 years. Since then, 
the number of available methods has increased signifi-
cantly.
 › By summer 2019, the German Federal Joint Commit-
tee (G-BA) will examine whether non-invasive prena-
tal tests (NIPTs) will become a benefit provided and 
reimbursed by the statutory health insurance scheme 
(GKV). NIPTs can detect certain genetic variations (e. g. 
trisomy 13, 18 or 21) of the foetus in the maternal blood.
 › The availability of low-risk NIPTs might lead to genetic 
examinations of the foetus becoming the norm. Thus, 
fundamental questions about prenatal diagnosis are 
raised with a new urgency, e. g. how discrimination 
against people with disabilities can be avoided without 
calling into question the right to a self-determined de-
sire to have children.
 › The debate that seems to be necessary for society as a 
whole could be initiated and characterised by parlia-
mentary activities.
What is involved
Prenatal diagnosis (PND) includes all prenatal examinations 
aimed at obtaining information about the unborn child. 
There is a number of examination methods, which are mostly 
divided into so-called invasive and non-invasive procedures 
(Fig. 2). Invasive procedures are associated with a puncture 
of the amnion or placenta and therefore involve higher pro-
cedural risks (e. g. of miscarriage) than non-invasive proce-
dures. Non-invasive procedures such as ultrasound exami-
nations, however, do not involve uterine interventions, but 
are not considered to be diagnostic. Consequently, they can 
only provide information on diagnoses that must be verified 
subsequently using other procedures.
Prenatal examinations make it possible to medically accom-
pany pregnancy and childbirth – especially in case of abnor-
malities – in such a way that damage to the expectant mother 
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counselling of pregnant women and abortion. These laws 
aim at ensuring informed consent to prenatal genetic testing, 
strengthening the provision of psychosocial counselling dur-
ing pregnancy, regulating how to cope with pregnancy con-
flicts and restricting abortions after the 12th week of preg-
nancy to particular cases of conflict.
In European neigh-
bouring states, very 
different offers, uses 





exist. Moreover, the 
accompanying so-
cietal debates also 
vary in intensity 
and focus on differ-
ent aspects.
The situation of pregnant women
In Germany, surveys of (pregnant) women and doctors show 
that most pregnant women use prenatal diagnostic services 
that go far beyond the three ultrasound screenings provided 
for in the maternity guidelines (Fig. 2). And they are willing 
to pay for this. At the same time, the majority of pregnant 
women do not have a precise understanding of prenatal di-
agnosis and consider it to be a standard option in prenatal 
care. They often hope that prenatal diagnostic procedures 
will confirm the health of their unborn child. In the majority 
of cases, however, it is prenatal diagnosis that only raises the 
fear that the unborn child could be disabled. First and fore-
most, the vast majority of pregnant women associate the pos-
sibility of having a disabled child with fears regarding their 
own autonomy in terms of time and money and regarding 
their life as a couple.
In their decisions on prenatal diagnosis, pregnant women 
rely primarily on the information provided by their attend-
ing doctor. For this reason, the task of the doctors is to in-
form patients with only little prior knowledge about prena-
tal diagnosis within the framework of their liability-related 
obligations to act and to advise them comprehensively and 
neutrally.
Societal and ethical issues
Prenatal diagnostic examinations and the handling of re-
sulting potentially serious diagnoses combine questions re-
tests can detect the trisomies 13, 18 and 21 as well as the 
foetal sex with high accuracy. They are not considered to be 
diagnostic, so that an abnormal finding should be verified 
using other, usually invasive procedures. NIPTs have been 
approved as a self-pay service for pregnant women in Ger-
many since 2012.
In the field of pre-
natal diagnosis and 
in particular in the 
field of new genetic 
analysis methods 
such as NIPTs, ef-
forts are being made 
by companies pro-
viding prenatal tests 
to develop and pat-
ent new, faster and 
diagnostically more 
comprehensive pro-
cedures. It is to be 
expected that many 
research institutions 
and research-based companies will extend prenatal diagnosis 
both in terms of its methodological diversity and its diagnostic 
scope. Thus, the volume of prenatally available genetic infor-
mation about foetuses and embryos would increase drastically.
Legal basis
With regard to NIPTs, there is a method evaluation procedure 
that will run until summer 2019. In this procedure, the Ger-
man Joint Federal Committee (G-BA) will decide whether 
non-invasive prenatal tests for trisomies 13, 18 and 21 should 
be offered free of charge to so-called women with high-risk 
pregnancies as part of the statutory health insurance scheme. 
In this context, there is no conclusive definition of a high-risk 
pregnancy with regard to a certain probability of developing 
a trisomy. So far, the method evaluation procedure for NIPTs 
has led to fierce controversies, particularly among parts of 
civil society. This debate focuses on the question of the extent 
to which prenatal diagnostic procedures that do not open up 
primary therapeutic options should be part of the statutory 
health insurance benefits. Critics of the tests argue that their 
primary purpose is to terminate pregnancies with disabled 
foetuses. They call for a broad societal debate on whether 
these tests are socially desirable and whether prenatal diag-
nosis is accompanied by an implicit value judgement about 
people with disabilities.
The German Genetic Diagnosis Act, the German Act on 
Assistance to Avoid and Cope with Conflict in Pregnancy 
and the German Criminal Code are the central foundations 
with regard to the regulation of prenatal genetic analyses, the 
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with their unborn child with reservations if the baby’s 
health has not yet been »confirmed« by prenatal diagno-
sis? Or is it simply a decision-making aid for expectant 
parents?
 › To what extent can NIPTs promote self-determined re-
productive decisions? Does it represent a discrimination 
against socially disadvantaged pregnant women if they 
may use invasive prenatal diagnostic procedures free of 
charge, but not NIPTs, which have no increased risk of 
miscarriage?
 › What challenges can result from gaining knowledge about 
the respective genetic findings for expectant parents, the 
concerned child and attending doctors? How much and 
what kind of genetic information of their unborn child 
should expectant parents be allowed to receive? How 
should findings with unclear clinical significance be dealt 
with?
Options for action
In summary, three central challenges can be identified with 
regard to the social use of prenatal diagnosis:
Gaps in knowledge regarding the current practice of prenatal 
diagnosis: The use of prenatal diagnosis and the consequenc-
es resulting from this use take place at decisive interfaces, as 
it were, in a »black box«. For example, there are no nation-
wide surveys covering all health insurance companies and 
institutions to determine which prenatal diagnostic proce-
dures are used by pregnant women with which intentions, 
what prior knowledge the pregnant women have, how they 
garding one’s personal life and individual decision-making in 
serious conflict situations with fundamental ethical and so-
cietal issues. On the one hand, this is due to the fact that the 
sum of individual decisions can have consequences for socie-
ty as a whole, for example when fewer and fewer children are 
born with prenatally recognisable, congenital disabilities. On 
the other hand, it seems imaginable that options for action 
opening up (e. g. due to new, low-risk test procedures) could 
involve a change in social values. If, for example, it is possible 
to prenatally diagnose a foetus with Down’s syndrome (tri-
somy 21) without any risk of intervention, will parents of a 
child with Down’s syndrome in future be under even higher 
pressure to justify their decision to continue or terminate the 
pregnancy?
Critics fear this scenario and point out that Down’s syndrome 
is by no means associated with suffering. In surveys, people 
with Down’s syndrome indicate a high level of satisfaction 
with their lives and the vast majority of families with children 
with Down’s syndrome do not »suffer« from the disability of 
their child or sibling – rather the opposite is true. Neverthe-
less, prenatal diagnosis particularly focuses on trisomy 21 
and many prenatal diagnostic procedures show a particular 
sensitivity to the detection of this syndrome (e. g. NIPTs). The 
question of whether the offer to prenatally recognise certain 
disabilities represents a value judgement about this disability 
is only one of many social and ethical questions regarding 
prenatal diagnosis. There are further questions with regard 
to the following aspects:
 › Does prenatal diagnosis change the perception of preg-
nancy and parenthood? Do pregnant women only bond 
Fig. 2 Prenatal diagnostic examinations in the course of pregnancy
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to birth. Stakeholders of central groups in society as well 
as the general public shall be invited to parti cipate in this 
exchange.
In view of the decision regarding the method evaluation 
procedure of the G-BA due in summer 2019, it is obvious 
that the German Bundestag – in its legislative function – 
will take up and actively shape the debate on the previous 
and future role of prenatal diagnosis. An essential question 
with regard to future regulation is whether German poli-
tics – as requested by numerous organisations from the 
churches and civil society – would like to prevent a further 
expansion of prenatal diagnosis and restrict access to PND 
or whether the objective should be to improve the detec-
tion of foetal malformations at the earliest possible stage in 
pregnancy. Both objectives are based on diverging concepts 
for action.
retrospectively assess the use of prenatal diagnosis and how 
often they get into conflict situations as a result of knowledge 
acquired by means of prenatal diagnosis.
The way individuals and society are dealing with the grow-
ing opportunities of genome analysis: The increased num-
ber of recognisable genetic peculiarities requires differentiat-
ed human genetic counselling in order to ensure an informed 
consent to genetic analyses. Due to the constantly increasing 
number of recognisable genetic peculiarities, the demands 
on counselling are increasing as well.
Difficult framework conditions for an informed decision 
by pregnant women: The current counselling and informa-
tion landscape is influenced by company interests, which also 
play a central role in communicating information on NIPTs 
to both pregnant women and doctors. Most pregnant wom-
en have limited knowledge of prenatal diagnosis. For them, 
their attending doctor is the most important source of infor-
mation. For their part, doctors report on time pressure dur-
ing counselling and treatment, a lack of resources for further 
training and concern about liability claims if they do not pro-
vide sufficiently clear information about prenatal diagnostic 
examinations and the resulting findings.
To respond to these challenges, there are options for ac-
tion in the fields of research and data acquisition, dia-
logue, counselling and participation as well as regulation. 
Research projects should examine the information needs 
of pregnant women, the social consequences of PND and 
the decision-making process in case of abnormal findings. 
With regard to an improvement of the counselling land-
scape, it would make sense to promote cooperation be-
tween doctors’ practices, hospitals and counselling centres, 
to expand the range of further training on offer and to con-
tinuously improve information material. In addition, assis-
tance for families with disabled or chronically ill children 
could be centralised and unbureaucratic support services 
could be expanded to ease the situation of these families. 
Finally, in parallel to the method evaluation procedure for-
NIPTs of the German Federal Joint Committee (G-BA), it 
seems desirable to initiate a broad social exchange on the 
opportunities and limitations of prenatal diagnosis and ge-
netic knowledge and on how to deal with disabilities prior 
